Multifunctional Cu<sub>3</sub>BiS<sub>3</sub>-BP@PEI Radiosensitizer with Enhanced Reactive Oxygen Species Activity for Multimodal Synergistic Therapy
Development of radiosensitizers with high-energy deposition efficiency, electron transfer, and oxidative stress amplification will help to improve the efficiency of radiotherapy. To overcome the drawbacks of radiotherapy alone, it is also crucial to design a multifunctional radiosensitizer that simultaneously realizes multimodal treatment and tumor microenvironment modulation. Herein, a multifunctional radiosensitizer based on the Cu<sub>3</sub>BiS<sub>3</sub>-BP@PEI nanoheterostructure (NHS) for multimodal cancer treatment is designed. Cu<sub>3</sub>BiS<sub>3</sub>-BP@PEI NHS is able to deposit a high radiation dose into cancer cells, enhancing the radiotherapy effect. Due to the heterostructure and the synergistic effect of Cu<sub>3</sub>BiS<sub>3</sub> and black phosphorus (BP), significantly boosted <sup>1</sup>O<sub>2</sub> and •OH generation is obtained under X-ray irradiation, which is promising for extremely efficient radiodynamic therapy. More importantly, the acidic tumor microenvironment (TME) can induce the cycle conversion of Cu<sup>2+</sup> to Cu<sup>+</sup>, oxidizing glutathione (GSH) and catalyzing intracellular overproduction of H<sub>2</sub>O<sub>2</sub> into highly toxic •OH, which thus further enhances reactive oxygen species (ROS) production and reduces GSH-associated radioresistance. Furthermore, Cu<sub>3</sub>BiS<sub>3</sub>-BP@PEI NHS has an excellent photothermal effect and can effectively transform light into heat. The outcomes of the in vitro and in vivo research confirm that the as-prepared Cu<sub>3</sub>BiS<sub>3</sub>-BP@PEI NHS has a high synergistic therapeutic efficacy at a low radiation dose. This work provides a viable approach to constructing a multifunctional radiosensitizer for deep tumor treatment with TME-triggered multiple synergistic therapies.
Authors
- Xiufeng Xiao (ORCID: https://orcid.org/0000-0001-7256-3935)
- Qingshuang Liang (ORCID: https://orcid.org/0000-0003-3659-3816)
- Hanping Fu
- Qing Zhang (ORCID: https://orcid.org/0000-0002-1160-2715)
- Yan Xie (ORCID: https://orcid.org/0000-0002-9103-9335)
- Shufen Ren
- Jiayun Cheng
Institutions
- Fujian Normal University (CN)
Publication Details
- Journal
- ACS Biomaterials Science & Engineering
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1021/acsbiomaterials.4c01907
- Citations
- 6
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 4.04
Funders
- Fuzhou Science and Technology Bureau
- Natural Science Foundation of Fujian Province